ADMET—turning chemicals into drugs


	Journal home

	Advance online publication

	Current issue

	Archive

	Press releases



	Supplements

	Focuses

	Conferences

Guide to authors


	NPG Resources

	Bioentrepreneur

	Nature Reviews Drug Discovery

	Nature

	Nature Medicine

	Nature Genetics

	Nature Reviews Genetics

	Nature Methods

	Nature Chemical Biology

	news@nature.com

	Clinical Pharmacology & Therapeutics

	Nature Conferences

Molecular Cell Biology

Neuroscience

Pharmacology

Physics

Browse all publications

Feature

Nature Biotechnology 19, 722 - 726 (2001)
doi:10.1038/90761

ADMET—turning chemicals into drugs

John Hodgson

John Hodgson is Nature Biotechnology's Editor-at-Large
(j.hodgson@biotechnology.com)

Rapidly resolving the pharmacokinetic and toxicological properties of drug candidates remains a key challenge for drug developers.

	Top

Abstract

Previous | Next

Table of contents


	Full text

	Download PDF

	Send to a friend

	Save this link

nature jobs

Faculty Position
- KAUST
- Jeddah Saudi Arabia
Postdoctoral position to study role of PI3K signaling and ER stress/UPR in cellular regeneration
- Shriners Hospital for Children/ University of Texas
- Galveston, TX

More science jobs

Post a job for free


	Figures & Tables


	Export citation






	Search buyers guide:


ISSN: 1087-0156 EISSN: 1546-1696	Journal home \| Advance online publication \| Current issue \| Archive \| Press releases \| Supplements \| Focuses \| Conferences \| For authors \| Online submission \| Permissions \| For referees \| Free online issue \| About the journal \| Contact the journal \| Subscribe \| Advertising \| work@npg \| naturereprints \| About this site \| For librarians


		©2001 Nature Publishing Group \| Privacy policy

ADMET—turning chemicals into drugs

nature jobs

Faculty Position

Postdoctoral position to study role of PI3K signaling and ER stress/UPR in cellular regeneration